Novel Blood Indicators of Progression and Prognosis in Renal Cell Carcinoma: Red Cell Distribution Width-to-Lymphocyte Ratio and Albumin-to-Fibrinogen Ratio

Table 1

Patient general clinical characteristics.

Characteristics	n (%)
Gender
Male	198 (72.5)
Female	75 (27.5)
Age (years)
≥65	54 (19.8)
<65	219 (80.2)
BMI (kg/m^2)
≥24	116 (42.5)
<24	157 (57.5)
Tumour size (D/cm)
<7	192 (70.3)
≥7	81 (29.7)
Tumour necrosis
Absent	148 (54.2)
Present	125 (45.8)
Tumour type
ccRCC	203 (74.4)
chRCC	15 (5.5)
pRCC	16 (5.9)
Others	39 (14.3)
T stage
T1	184 (67.4)
T2	52 (19.0)
T3	26 (10.6)
T4	8 (2.9)
N stage
N0	258 (94.5)
N1	15 (5.5)
M stage
M0	255 (93.4)
M1	18 (6.6)
TNM stage
I	180 (65.9)
II	48 (17.6)
III	28 (10.3)
IV	17 (6.2)
Fuhrman grade
G1	47 (17.2)
G2	117 (42.9)
G3	94 (34.4)
G4	15 (5.5)